Disc Medicine, Inc.
IRON
$59.14
-$0.85-1.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -105.49% | -134.30% | -109.65% | -26.48% | -24.93% |
| Total Depreciation and Amortization | 888.89% | 690.91% | -22.73% | -23.08% | -64.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 268.61% | 344.41% | 90.87% | -0.71% | 341.90% |
| Change in Net Operating Assets | 1,785.74% | -14.51% | -96.07% | -5.56% | -109.54% |
| Cash from Operations | -57.04% | -175.32% | -211.30% | -23.15% | -54.94% |
| Capital Expenditure | 95.55% | -425.00% | -1,300.00% | -1,170.15% | -14,866.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22,711.98% | 169.71% | 123.54% | -- | -- |
| Cash from Investing | -15,530.65% | 169.68% | 123.52% | -406,814.93% | -47,433.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17,536.11% | 2,620.19% | -99.48% | 1,377.14% | -84.51% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 436.68% | -- | -- | -- | -- |
| Cash from Financing | 652.43% | 2,620.19% | -99.48% | 1,436.17% | 271.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24,413.37% | 115.14% | 107.53% | -292.65% | 97.99% |